Typical Daily Schedule

• 8:00 am – Morning Meeting and Breakfast
• 9:00 am – Welcome and Program Introduction
• 9:30 am – Visit the Neuron Observatory
• 10:00 am – Visit to the Neurophysiology Lab
• 12:00 pm – Lunch
• 1:00 pm – Neuroanatomy with Human Brain
• 3:30 pm – Introduction to Artificial Intelligence
• 4:30 pm – Neuroimaging Experiments
• 5:00 pm – Debrief for the Next Day
• 5:30 pm – Dinner
• 6:30 pm – Evening Activities
• 7:30 pm – Free Time
• 9:00 pm – Prepare for Bed
• 10:30 pm – Lights Out

* The “A Day in the Life” sample schedule is subject to change. 

Dr. Anthony Sali

Academic Leader, Neuroscience Institute

Anthony Sali earned his Ph.D. in Psychological and Brain Sciences from the Johns Hopkins University in 2015. He then completed a postdoctoral fellowship at the Center for Cognitive Neuroscience at Duke University. Anthony joined the faculty of the psychology department at Wake Forest University as an assistant professor in the fall of 2018. As a cognitive neuroscientist, Dr. Sali uses a combination of studies of human behavior, eye tracking, human functional magnetic resonance imaging (fMRI), and electroencephalography (EEG) to investigate the neural mechanisms and behavioral consequences of attentional control. In particular, researchers in the Sali Lab are focused on understanding how individuals harness learned expectations to anticipate future demands and adapt the flexibility of goal-directed attention. Dr. Sali’s research has implications for understanding healthy cognitive abilities as well as disorders of control such as attention deficit hyperactivity disorder, drug abuse, and anxiety.

Dr. Katie Holleran

Academic Leader, Neuroscience Institute

Katie Holleran received her Ph.D. in Neuroscience at Vanderbilt University in 2016 under the mentorship of Dr. Danny Winder. She then began her postdoctoral training in the laboratory of Dr. Sara Jones, and is currently an Instructor in the Physiology and Pharmacology department in the Jones lab. Dr. Holleran has been interested throughout her career in alcohol use disorder and so-called disorders of negative affect, such as depression, anxiety, and post-traumatic stress disorder. She explores how exposure to stress and/or chronic alcohol may drive depression- or anxiety-like states in rodent models, and how innate vulnerabilities may predispose certain populations to the development of these disorders. Dr. Holleran primarily uses behavioral techniques, electrochemistry (fast scan cyclic voltammetry in rodent brain slices), and virally-mediated genetic tools to assess alterations in the dopamine system following exposure to stress and/or alcohol. She is interested in potential treatments to alleviate these conditions, and is currently focused on the kappa opioid receptor/dynorphin system as a therapeutic target.